Cannabidiol - an in Vivo Innovative Drug Delivery Study

Stopped Two step study, step two was not feasible based on results from phase one.

Conditions

• Pharmacokinetics, Bioavailability

Interventions

• DRUG: Cannabidiol

Sponsor

Central Institute of Mental Health, Mannheim